Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

7.8 (USD) • At close January 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -95.842-97.54-91.373-92.996-93.017-76.726-65.327-57.492-60.445-65.56-55.979-64.933-47.428-43.401-30.717-25.766-23.873-18.943-18.424
Depreciation & Amortization 7.19887.415.6167.5785.5433.7283.2142.9892.7862.7672.2362.4362.3311.4021.6240.8571.0240.937
Deferred Income Tax 000-54.0570.01900000000.8270001.75700
Stock Based Compensation 18.25316.52416.12716.08616.79211.8118.8147.6958.9075.6755.6324.3413.3635.3171.8211.1881.070.7691.265
Change In Working Capital 46.715-10.264-36.451-11.27-4.462-10.121-24.404-0.601-7.765-9.537122.824-3.9597.29-0.275-3.36231.5540.280.617-1.617
Accounts Receivables 0.3040.736-1.04-6.422-0.203-0.814-0.3175.5723.777-8.086-1.265-5.3760.0160.0130.08530.043-30.190.060.082
Change In Inventory 000-1.3340.2030.8140.317-5.572-3.7778.086006.6442.141-2.9984.233000
Change In Accounts Payables -1.513-1.3421.168-0.3172.186-2.517-0.3390.6950.714-0.9861.344-3.5073.130.0712.051-0.222-0.055-0.5330.625
Other Working Capital 47.924-9.658-36.579-4.531-6.648-7.604-24.065-1.296-8.479-8.551121.48-0.452-2.5-2.5-2.5-2.530.5251.09-2.324
Other Non Cash Items -35.54934.19132.79652.5440.172.0263.8732.4361.7735.0132.1441.1570.4642.3750.101-0.0270.453-0.1660.022
Operating Cash Flow -59.225-82.219-102.3-74.077-72.92-67.467-73.316-44.748-54.541-61.62377.388-61.158-33.048-33.653-30.7558.573-19.456-16.699-17.817
Investing Activities:
Investments In Property Plant And Equipment -1.562-4.182-6.653-2.417-0.827-3.968-5.34-7.979-8.563-16.475-4.342-4.464-9.706-6.212-19.416-4.591-0.826-0.634-0.684
Acquisitions Net 000-0.07101.91500000-184.1670000-2.600
Purchases Of Investments 00000000000-116.97-184.167000000
Sales Maturities Of Investments 00000.4800061.54721.415147.64669.1910000000
Other Investing Activites -3-30-0.350.3980-0.165-0.361.24721.415147.646184.167-184.16700-0.904-2.60.5950
Investing Cash Flow -4.562-4.182-6.653-2.488-0.347-2.053-5.34-7.97952.9844.94143.304-52.243-193.873-6.212-19.416-4.591-3.426-0.039-0.684
Financing Activities:
Debt Repayment -2.287-0.026-0.026-0.694-0.024-0.024-0.024-0.023-0.023-0.022-0.022-0.021-12.737-0.02-0.02-0.02-0.020.3825.981
Common Stock Issued 16.968261.54610.87378.093503.8111.946143.7112.362.692.106462.9011.642463.7252.1540000
Common Stock Repurchased 0000000000000000000
Dividends Paid 0000000000000000000
Other Financing Activities 1.7811.6023.053.263.7893.8111.9463.5682.362.692.1063.8171.642463.7252.15410.055229.74100.016
Financing Cash Flow 16.462263.12213.89780.65953.7653.7871.922147.2562.3372.6682.0843.796-11.095463.7052.13410.035229.7210.3825.997
Other Information:
Effect Of Forex Changes On Cash 0.403-0.118-0.2190.124-0.1150.181-0.002-0.30700000000000
Net Change In Cash -40.293176.603-95.2755.218-19.617-65.552-76.73694.2220.78-54.015222.776-109.605-238.016423.84-48.03714.017206.839-16.356-12.504
Cash At End Of Period 435.831476.124299.521394.796397.207416.824482.376559.112464.89464.11518.125295.349404.954642.97219.13267.167253.1546.31162.667